Concepedia

Publication | Open Access

Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma

DOIFull Paper Access

43

Citations

17

References

2022

Year

Xi Wang, Chengsheng Zhang, Xuyuan Dong, Yuan Hu, Baojun Duan, Jun Bai, Yinying Wu, Fan Lin, Xin-Hua Liao, Kang Ye,
World Journal of Gastrointestinal Oncology

Abstract

CLDN18.2 expression is frequently increased in PDAC patients. Thus, it may act as a potential therapeutic target for zolbetuximab in PDAC.

References

YearCitations

Page 1